Sordarin antifungal agents

Bibliography

• HAUSER D, SIGG HP: Isolierung und Abbau von Sordarin. Helv. Chim. Acta (1971) 54:1178–1190.
   PubMed Web of Science ®Google Scholar
• VASELLA A: Uber em neuartiges Diterpen aus Sordaria Araneosa Cain. PhD thesis. Eidgenössischen Technischen Hochschule, Zurich (1972)
   Google Scholar
• ARIGONI D, VASELLA A, SHARPLESS K, JENSEN H: Selenium dioxide oxidations of olefins. Trapping of the allylic seleninic acid intermediate as a seleninolac-tone. J. Amer. Chem. Soc. (1973) 95:7917–7919.
   Google Scholar
• OKADA H, KAMIYA S, SHIINA Y et al.: BE-31405, a new antifungal anproduced by Penicillium miniolu- teum - I. Description of producing organism, fermentation, isolation, physico-chemical and biological properties. J Antibiot. (1998) 51:1081–1086.
   Google Scholar
• COVAL SJ, PUAR MS, PHIFE DW, TERRACCIANO JS, PATEL M: SCH57404, an antifungal agent possessing the rare sodaricin skeleton and a tricyclic sugar moiety. J Antibiot. (1995) 48:1171–1172.
   PubMed Web of Science ®Google Scholar
• KINSMAN OS, CHALK PA, JACKSON HC et al: Isolation and characterisation of an antifungal antibiotic (GR135402) with protein synthesis inhibition. J. Antibiot. (1998) 51:41–49.
   PubMed Web of Science ®Google Scholar
• •Description of original discovery of sordarins as protein synthesis inhibitors.
   Google Scholar
• GARGALLO-VIOLA D: Sordarins as antifungal compounds. Curr. Opin. AntiInfect. Invest. Drugs (1999) 1:297–305.
   Google Scholar
• •Review of the status of the sordarin series in 1999.
   Google Scholar
• KENNEDY T, WEBB G, CANNELL R et al: Novel inhibitors of fungal protein synthesis produced by a strain of Graphium putredinis. J. Antibiot. (1998) 51:1012–1018.
   PubMed Web of Science ®Google Scholar
• DAFERNER M, MENSCH S, ANKE T, STERNER 0: Hypoxy-sordarin, a new sordarin derivative from Hypoxylon croceum. Z. Naturforsch. C-j BioscL (1999) 54:474–480.
   PubMedGoogle Scholar
• CUEVAS JC, MARTOS JL: Synthesis of a monocyclic core of the antifungal sordarins. Tetrahedron Lett. (1998) 39:8553–8556.
   Web of Science ®Google Scholar
• HERREROS E, MARTINEZ CM, ALMELA MJ, MARRIOTT MS,HERAS FGD, GARGALLOVIOLA D: Sordarins - in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii and filamen-tous fungi. Antimicrob. Agents Chemother. (1998) 42:2863–2869.
   PubMed Web of Science ®Google Scholar
• •The most extensive report to date of the antifungal activities of sordarins in vitro.
   Google Scholar
• TSE B, BALKOVEC JM, BLAZEY CM, HSU MJ, NIELSEN J, SCHMATZ D: Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast. Bioorgan. Med. Chem. Lett. (1998) 8:2269–2272.
   PubMed Web of Science ®Google Scholar
• ALVAREZ M, HERREROS E, SAMCHEZ-SOUSA A, GARGALLO-VIOLA D, BAQUERO F: In vitro activity of sordarins in combination with other systemic antifungal agents against Candida albicans, Aspergillus spp. and Scedosporium apiospermum. 38th Meeting of the Intel-sciences Conference on Antimicro-bial Agents and Chemotherapy (1998), Abstract J012.
   Google Scholar
• HERREROS E, MARTINEZ C, ALMELA M, LOZANO S, GOMEZ DE LAS HERAS F, GARGALLO-VIOLA D: Fungicidal activity of sordarins against Candida albicans determined by time-kill methods. 38th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (1998), Abstract J013
   Google Scholar
• HERREROS E, ALMELA MJ, LOZANO S, GARGALLO-VIOLA D: Investigation of in vitro development of resistance to azasordarins in Candida albicans. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 202.
   Google Scholar
• DOMINGUEZ JM, KELLY VA, KINSMAN OS, MARRIOTT MS, DELASHERAS FG, MARTIN JJ: Sordarins - a new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob. Agents Chemother. (1998) 42:2274–2278.
   PubMed Web of Science ®Google Scholar
• DOMINGUEZ JM, MARTIN JJ: Identification of elonga-tion factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob. Agents Chemother. (1998) 42:2279–2283.
   PubMed Web of Science ®Google Scholar
• CAPA L, MENDOZA A, LAVANDERA JL, GOMEZ DE LAS HF,GARCIA-BUSTOS JF: Translation elongation factor 2 is part of the target for a new family of antifungals. Antimicrob. Agents Chemother. (1998) 42:2694–2699.
   PubMed Web of Science ®Google Scholar
• JUSTICE MC, HSU MJ, TSE B, KU T, BALKOVEC J, SCHMATZD, NIELSEN J: Elongation factor 2 as a novel target for selective inhibition of fungal protein synthesis. j Biol. Chem. (1998) 273:3148–3151.
   PubMed Web of Science ®Google Scholar
• COLTHURST DR, SCHAUDER BS, HAYES MV, TUITE MF:Elongation-factor-3 from Candida albicans shows both structural and functional similarity to ef-3 from Saccharomyces cerevisiae. Mol. Microbiol (1992)6:1025–1033.
   PubMed Web of Science ®Google Scholar
• BELFIELD G, TUITE M: Translation elongation factor-3 -a fungus-specific translation factor. Mol. Microbiol. (1993) 9:411–418.
   PubMed Web of Science ®Google Scholar
• JUSTICE MC, HSU MJ, TSE B et al: Elongation factor 2 as anovel target for selective inhibition of fungal protein synthesis. J Biol. Chem. (1998) 273:3148–3151.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LORENZO MG, GARCIA-BUSTOS JF: RibosomalP-protein stalk function is targeted by sordarin antifungals. J Biol Chem (1998) 273:25041–25044.
   PubMed Web of Science ®Google Scholar
• JUSTICE MC, KU T, HSU MJ, CARNIOL K, SCHMATZ D, NIELSEN J: Mutations in ribosomal protein LIOe confer resistance to the fungal-specific eukaryotic elongation factor 2 inhibitor sordarin. J Biol. Chem. (1999) 274:4869–4875.
   PubMed Web of Science ®Google Scholar
• GOMEZ-LORENZO MG, SPAHN CM, AGRAWAL RK et al.:Three-dimensional cryo-electron microscopy localization of EFL in the Saccharomyces cerevisiae 80S ribosome at 17.5 A resolution. EMBO j (2000) 19:2710–2718.
   Google Scholar
• DOMINGUEZ JM, GOMEZ-LORENZO MG, MARTIN JJ: Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid. J Biol. Chem. (1999) 274:22423–22427.
   PubMed Web of Science ®Google Scholar
• SHASTRY M, NIELSEN J, KU T et al.: Species specificinhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2. Microbiology (2000): In press.
   Google Scholar
• •Outstanding account of the research that shows just three amino acids in EF-2 account for the high antifungal specificity of the sordarin inhibitors.
   Google Scholar
• AVILES P, FALCOZ C, SAN ROMAN R, GARGALLO-VIOLA D: Ph armacokinetics-ph armacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis. Antimicrob. Agents Chemother. (2000) 44:2333–2340.
   PubMed Web of Science ®Google Scholar
• •Excellent study of the activity of sordarins in vivo.© Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (2001) 11(2)
   Google Scholar
• AVILES P, MARTINEZ A, SAN ROMAN R, GUILLEN M, JIMINEZ E, GARGALLO-VIOLA D: Therapeutic efficacy of GW 531920, a new azasordarin derivative, in systemic candidiasis in mice. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 1692.
   Google Scholar
• AVILES P, ALIOUAT EM, MARTINEZ A et al: In vitropharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats. Antimicrob. Agents Chemother. (2000) 44:1284–1290.
   PubMed Web of Science ®Google Scholar
• MARTINEZ A, JIMENEZ E, ALIOUAT EM, CABALLERO J,DEI-CAS E, GARGALLO-VIOLA D: In vivo activity of azasordarins against two rat models of pneumocys-tosis. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 1096.
   Google Scholar
• MARTINEZ A, FERRER S, JIMENEZ E, SPARROWE J,CABALLERO J, GARGALLO-VIOLA D: Antifungal activity of azasordarins against oral and vaginal candidiasis in immunosuppressed rats. 40th Meeting of the Intersci-ences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 1689.
   Google Scholar
• GRAYBILL JR, NAJVAR L, FOTHERGILL A, BOCANEGRA R,LAS HERAS FG: Activities of sordarins in murine histoplasmosis. Antimicrob. Agents Chemother. (1999) 43:1716–1718.
   PubMed Web of Science ®Google Scholar
• AVILES P, PATEMAN A, SAN ROMAN R, GUILLEN M, GARGALLO-VIOLA D: Pharmacokinetic parameters of azasordarin derivatives (GW 471558 and GW 531920) after intravenous administration. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 1690.
   Google Scholar
• HERREROS E, MARTINEZ A, ALMELA M et al.: Preliminarytoxicology of azasordarins. 40th Meeting of the Intersci-ences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 1691.
   Google Scholar
• DOMINGUEZ JM, KELLY VA, KINSMAN OS, MARRIOTT MS,GOMEZ DE LAS HF, MARTIN JJ: Sordarins: anew class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob. Agents Chemother. (1998) 42:2274–2278.
   PubMed Web of Science ®Google Scholar
• HERREROS E, MARTINEZ CM, ALMELA MJ, MARRIOTT MS,LAS HERAS FG, GARGALLO-VIOLA D: Sordarins: in vitro activities of new antifun gal derivatives against pathogenic yeasts, Pneumocystis carinii and filamen-tous fungi. Antimicrob. Agents Chemother. (1998) 42:2863–2869.
   PubMed Web of Science ®Google Scholar
• HERREROS E, ALMELA MJ, LOZANO S, MARTINEZ CM, GARGALLO-VIOLA D: In vitro activity of azasordarins against clinical isolates of yeasts and filamentous fungi. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 201.
   Google Scholar
• LOZANO-CHIU M, PAETZNICK VL, RODRIGUEZ JR, REX J:Anti-Candida activity of the sordarin derivatives GW471552, GW471558, GW506540, GW531920 and GW560849: effect of endpoint rule and incubation time on MIC. 40th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (2000), Abstract 192.
   Google Scholar
• CLEMONS KV, STEVENS DA: Efficacies of sordarin derivatives GM193663, GM211676 and GM237354 in a murine model of systemic coccidioidomycosis. Antimi-crob. Agents Chemother. (2000) 44:1874–1877.
   PubMed Web of Science ®Google Scholar
• STEVENS DA: Screening of sordaricin derivatives against endemic fungal pathogens. 37th Meeting of the Intel-sciences Conference on Antimicrobial Agents and Chemotherapy (1997), Abstract F58.
   Google Scholar